{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:58:18Z","timestamp":1790834298019,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.molmed.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:10:51Z","timestamp":1600157451000},"page":"913-923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism"],"prefix":"10.1016","volume":"26","author":[{"given":"Nahid","family":"Tayebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisel","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.07.004_bb0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.07.004_bb0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"Alpha-synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.004_bb0025","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/brain\/awz350","article-title":"Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia","volume":"143","author":"Blauwendraat","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmg.2018.05.005","article-title":"Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease","volume":"62","author":"Ruskey","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0040","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.07.004_bb0045","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/15548627.2015.1067364","article-title":"Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease","volume":"11","author":"Gan-Or","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2020.07.004_bb0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12035-012-8327-0","article-title":"Alpha-synuclein and neuronal cell death","volume":"47","author":"Yasuda","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0055","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson's disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35811-8","article-title":"Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.07.004_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-017-1719-5","article-title":"Regulation of cathepsin D activity by the FTLD protein progranulin","volume":"134","author":"Zhou","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0080","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-018-1861-8","article-title":"The lysosomal function of progranulin, a guardian against neurodegeneration","volume":"136","author":"Paushter","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0090","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.neurobiolaging.2011.06.017","article-title":"Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling","volume":"32","author":"Xu","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2020.07.004_bb0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2020.07.004_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-017-0205-9","article-title":"Lysosomal processing of progranulin","volume":"12","author":"Zhou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.molmed.2020.07.004_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.022","article-title":"The protective role of prosaposin and its receptors in the nervous system","volume":"1585","author":"Meyer","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.molmed.2020.07.004_bb0110","first-page":"69","article-title":"Age- and sex-associated changes in prosaposin and its receptors in the lacrimal glands of rats","volume":"35","author":"Islam","year":"2020","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0115","first-page":"1017","article-title":"Targeting exogenous beta-defensin to the endolysosomal compartment via a vehicle guided system","volume":"32","author":"Carvelli","year":"2017","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0120","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1074\/jbc.M113.510883","article-title":"GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability","volume":"289","author":"Lundius","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fnmol.2019.00132","article-title":"Neuronal cells rearrangement during aging and neurodegenerative disease: metabolism, oxidative stress and organelles dynamic","volume":"12","author":"Castelli","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.004_bb0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jnc.14110","article-title":"The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C","volume":"143","author":"Zhou","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0135","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.yexcr.2009.08.016","article-title":"The inactivation of the sortilin gene leads to a partial disruption of prosaposin trafficking to the lysosomes","volume":"315","author":"Zeng","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molmed.2020.07.004_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.14125","volume":"143","author":"Van Damme","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0145","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","article-title":"Progranulin stimulates the in vitro maturation of pro-cathepsin D at acidic pH","volume":"431","author":"Butler","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1997.9958","article-title":"Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside","volume":"341","author":"Hiraiwa","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2020.07.004_bb0155","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1021\/bi00291a021","article-title":"Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes beta-glucuronidase and cathepsin D","volume":"22","author":"Erickson","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmed.2020.07.004_bb0160","doi-asserted-by":"crossref","first-page":"21738","DOI":"10.1016\/S0021-9258(19)36674-8","article-title":"The role of the cathepsin D propeptide in sorting to the lysosome","volume":"267","author":"Conner","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.02.008","article-title":"Cathepsin D -- many functions of one aspartic protease","volume":"68","author":"Benes","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0170","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmed.2020.07.004_bb0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/med.21394","article-title":"The role of cathepsin D in the pathogenesis of human neurodegenerative disorders","volume":"36","author":"Vidoni","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.molmed.2020.07.004_bb0180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0005-2760(81)90134-X","article-title":"Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein)","volume":"664","author":"Berent","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2020.07.004_bb0185","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0190","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neurobiolaging.2017.05.009","article-title":"NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases","volume":"57","author":"Blauwendraat","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2020.07.004_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-017-1147-9","article-title":"Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing","volume":"18","author":"Jansen","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","article-title":"Genetic risk factors in Parkinson's disease","volume":"373","author":"Billingsley","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.molmed.2020.07.004_bb0210","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mds.27659","article-title":"Parkinson's disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms","volume":"34","author":"Blauwendraat","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2020.07.004_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0860-4","article-title":"GBA-associated Parkinson's disease and other synucleinopathies","volume":"18","author":"Gan-Or","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.molmed.2020.07.004_bb0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.11.015","article-title":"Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics","volume":"73","author":"Senkevich","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.molmed.2020.07.004_bb0225","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/brain\/awaa064","article-title":"Variants in saposin D domain of prosaposin gene linked to Parkinson's disease","volume":"143","author":"Oji","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnins.2018.00230","article-title":"Pleiotropic effects of variants in dementia genes in Parkinson disease","volume":"12","author":"Ibanez","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2020.07.004_bb0235","doi-asserted-by":"crossref","first-page":"e1901","DOI":"10.1038\/cddis.2015.283","article-title":"Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of \u03b1-synuclein aggregates","volume":"6","author":"Bae","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2020.07.004_bb0240","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","article-title":"Characterization of brain lysosomal activities in GBA-related and sporadic Parkinson's disease and dementia with Lewy bodies","volume":"56","author":"Moors","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease","volume":"7","author":"Do","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0250","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2020.07.004_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2013.01.012","article-title":"Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data","volume":"108","author":"Maniwang","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2020.07.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/npjparkd.2016.4","article-title":"SCARB2 variants and glucocerebrosidase activity in Parkinson's disease","volume":"2","author":"Alcalay","year":"2016","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.molmed.2020.07.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160501","article-title":"Mannose 6-phosphate receptor is reduced in \u03b1-synuclein overexpressing models of Parkinsons disease","volume":"11","author":"Matrone","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.07.004_bb0270","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.R800035200","article-title":"Proteases: multifunctional enzymes in life and disease","volume":"283","author":"Lopez-Otin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104620","article-title":"Glucocerebrosidase activity, cathepsin D and monomeric alpha-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation","volume":"134","author":"Yang","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2020.07.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026454","article-title":"Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins","volume":"6","author":"Almeida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.07.004_bb0285","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","article-title":"Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients","volume":"26","author":"Valdez","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0290","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.07.004_bb0295","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.10.010","article-title":"Progranulin recruits HSP70 to beta-glucocerebrosidase and is therapeutic against Gaucher disease","volume":"13","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2020.07.004_bb0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between progranulin and Gaucher disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2020.07.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212382","article-title":"Progranulin deficiency leads to reduced glucocerebrosidase activity","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.07.004_bb0310","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s40478-019-0872-6","article-title":"Impaired beta-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations","volume":"7","author":"Arrant","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molmed.2020.07.004_bb0315","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2019.07.014","article-title":"Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease","volume":"128","author":"Afinogenova","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2020.07.004_bb0320","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/973231","article-title":"A guided tour of the structural biology of Gaucher disease: acid-beta-glucosidase and saposin C","volume":"2011","author":"Lieberman","year":"2011","journal-title":"Enzyme Res."},{"key":"10.1016\/j.molmed.2020.07.004_bb0325","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1093\/hmg\/ddv153","article-title":"BCM-95 and (2-hydroxypropyl)-beta-cyclodextrin reverse autophagy dysfunction and deplete stored lipids in Sap C-deficient fibroblasts","volume":"24","author":"Tatti","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.molmed.2020.07.004_bb0335","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.02.028","article-title":"Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain","volume":"67","author":"Hallett","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2020.07.004_bb0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0345","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0350","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/hmg\/ddz229","article-title":"Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity","volume":"29","author":"Valdez","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0355","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.1074\/jbc.R112.399170","article-title":"Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration","volume":"287","author":"Cenik","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.07.004_bb0360","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1110\/ps.073295308","article-title":"Structure dissection of human progranulin identifies well-folded granulin\/epithelin modules with unique functional activities","volume":"17","author":"Tolkatchev","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.molmed.2020.07.004_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15277","article-title":"Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.07.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0100-17.2017","article-title":"Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations","volume":"4","author":"Holler","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.molmed.2020.07.004_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2478\/v10042-008-0003-x","article-title":"Human cathepsin D","volume":"46","author":"Minarowska","year":"2008","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0380","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-1-17","article-title":"Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity","volume":"1","author":"Qiao","year":"2008","journal-title":"Mol. Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.molmed.2020.07.004_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004010050960","article-title":"Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant","volume":"97","author":"Pampols","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2020.07.004_bb0395","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ymgme.2011.09.010","article-title":"Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy","volume":"104","author":"Tylki-Szymanska","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2020.07.004_bb0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14728222.2020.1733970","article-title":"Glucocerebrosidase as a therapeutic target for Parkinson's disease","volume":"24","author":"Chen","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.molmed.2020.07.004_bb0405","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mds.27903","article-title":"Substrate reduction therapy for GBA1-associated Parkinsonism: are we betting on the wrong mouse?","volume":"35","author":"Sidransky","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2020.07.004_bb0410","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awx198","article-title":"Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease","volume":"140","author":"Chitramuthu","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2020.07.004_bb0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2019.01.002","article-title":"Progranulin: a conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases","volume":"45","author":"Cui","year":"2019","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420301830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420301830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:21:14Z","timestamp":1761463274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491420301830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1471491420301830"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.07.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}